|
US3536809A
(en)
|
1969-02-17 |
1970-10-27 |
Alza Corp |
Medication method
|
|
US3598123A
(en)
|
1969-04-01 |
1971-08-10 |
Alza Corp |
Bandage for administering drugs
|
|
US3845770A
(en)
|
1972-06-05 |
1974-11-05 |
Alza Corp |
Osmatic dispensing device for releasing beneficial agent
|
|
US3916899A
(en)
|
1973-04-25 |
1975-11-04 |
Alza Corp |
Osmotic dispensing device with maximum and minimum sizes for the passageway
|
|
US4008719A
(en)
|
1976-02-02 |
1977-02-22 |
Alza Corporation |
Osmotic system having laminar arrangement for programming delivery of active agent
|
|
US4328245A
(en)
|
1981-02-13 |
1982-05-04 |
Syntex (U.S.A.) Inc. |
Carbonate diester solutions of PGE-type compounds
|
|
US4410545A
(en)
|
1981-02-13 |
1983-10-18 |
Syntex (U.S.A.) Inc. |
Carbonate diester solutions of PGE-type compounds
|
|
US4409239A
(en)
|
1982-01-21 |
1983-10-11 |
Syntex (U.S.A.) Inc. |
Propylene glycol diester solutions of PGE-type compounds
|
|
ES8702440A1
(es)
|
1984-10-04 |
1986-12-16 |
Monsanto Co |
Un procedimiento para la preparacion de una composicion de polipeptido inyectable sustancialmente no acuosa.
|
|
IE58110B1
(en)
|
1984-10-30 |
1993-07-14 |
Elan Corp Plc |
Controlled release powder and process for its preparation
|
|
US5033252A
(en)
|
1987-12-23 |
1991-07-23 |
Entravision, Inc. |
Method of packaging and sterilizing a pharmaceutical product
|
|
US5052558A
(en)
|
1987-12-23 |
1991-10-01 |
Entravision, Inc. |
Packaged pharmaceutical product
|
|
US5073543A
(en)
|
1988-07-21 |
1991-12-17 |
G. D. Searle & Co. |
Controlled release formulations of trophic factors in ganglioside-lipsome vehicle
|
|
US5612059A
(en)
|
1988-08-30 |
1997-03-18 |
Pfizer Inc. |
Use of asymmetric membranes in delivery devices
|
|
IT1229203B
(it)
|
1989-03-22 |
1991-07-25 |
Bioresearch Spa |
Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative.
|
|
PH30995A
(en)
|
1989-07-07 |
1997-12-23 |
Novartis Inc |
Sustained release formulations of water soluble peptides.
|
|
US5258357A
(en)
|
1989-10-07 |
1993-11-02 |
Basf Aktiengesellschaft |
Carboxamides, their preparation and their use as herbicides
|
|
DE3933573A1
(de)
|
1989-10-07 |
1991-04-18 |
Basf Ag |
Carbonsaeureamide, verfahren zu ihrer herstellung und ihre verwendung als herbizide
|
|
US5120548A
(en)
|
1989-11-07 |
1992-06-09 |
Merck & Co., Inc. |
Swelling modulated polymeric drug delivery device
|
|
US5585112A
(en)
|
1989-12-22 |
1996-12-17 |
Imarx Pharmaceutical Corp. |
Method of preparing gas and gaseous precursor-filled microspheres
|
|
IT1246382B
(it)
|
1990-04-17 |
1994-11-18 |
Eurand Int |
Metodo per la cessione mirata e controllata di farmaci nell'intestino e particolarmente nel colon
|
|
US5733566A
(en)
|
1990-05-15 |
1998-03-31 |
Alkermes Controlled Therapeutics Inc. Ii |
Controlled release of antiparasitic agents in animals
|
|
US5543390A
(en)
|
1990-11-01 |
1996-08-06 |
State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University |
Covalent microparticle-drug conjugates for biological targeting
|
|
US5399564A
(en)
|
1991-09-03 |
1995-03-21 |
Dowelanco |
N-(4-pyridyl or 4-quinolinyl) arylacetamide and 4-(aralkoxy or aralkylamino) pyridine pesticides
|
|
CA2119155C
(en)
|
1991-10-18 |
1999-06-15 |
Dennis Paul Phillion |
Fungicides for the control of take-all disease of plants
|
|
US5580578A
(en)
|
1992-01-27 |
1996-12-03 |
Euro-Celtique, S.A. |
Controlled release formulations coated with aqueous dispersions of acrylic polymers
|
|
US5323907A
(en)
|
1992-06-23 |
1994-06-28 |
Multi-Comp, Inc. |
Child resistant package assembly for dispensing pharmaceutical medications
|
|
HRP921338B1
(en)
|
1992-10-02 |
2002-04-30 |
Monsanto Co |
Fungicides for the control of take-all disease of plants
|
|
US5248221A
(en)
|
1992-10-22 |
1993-09-28 |
Rohm And Haas Company |
Antifouling coating composition comprising lactone compounds, method for protecting aquatic structures, and articles protected against fouling organisms
|
|
US5334389A
(en)
|
1992-10-15 |
1994-08-02 |
Duke University |
Antifouling coating and method for using same
|
|
US5259701A
(en)
|
1992-10-22 |
1993-11-09 |
Rohm And Haas Company |
Antifouling coating composition comprising furan compounds, method for protecting aquatic structures, and articles protected against fouling organisms
|
|
TW333456B
(en)
|
1992-12-07 |
1998-06-11 |
Takeda Pharm Ind Co Ltd |
A pharmaceutical composition of sustained-release preparation the invention relates to a pharmaceutical composition of sustained-release preparation which comprises a physiologically active peptide.
|
|
US5591767A
(en)
|
1993-01-25 |
1997-01-07 |
Pharmetrix Corporation |
Liquid reservoir transdermal patch for the administration of ketorolac
|
|
US6274552B1
(en)
|
1993-03-18 |
2001-08-14 |
Cytimmune Sciences, Inc. |
Composition and method for delivery of biologically-active factors
|
|
US5985307A
(en)
|
1993-04-14 |
1999-11-16 |
Emory University |
Device and method for non-occlusive localized drug delivery
|
|
US5523092A
(en)
|
1993-04-14 |
1996-06-04 |
Emory University |
Device for local drug delivery and methods for using the same
|
|
US5571813A
(en)
|
1993-06-10 |
1996-11-05 |
Beiersdorf-Lilly Gmbh |
Fused pyrimidine compounds and their use as pharmaceuticals
|
|
US6087324A
(en)
|
1993-06-24 |
2000-07-11 |
Takeda Chemical Industries, Ltd. |
Sustained-release preparation
|
|
US6004534A
(en)
|
1993-07-23 |
1999-12-21 |
Massachusetts Institute Of Technology |
Targeted polymerized liposomes for improved drug delivery
|
|
IT1266582B1
(it)
|
1993-07-30 |
1997-01-09 |
Recordati Chem Pharm |
Derivati (di)azacicloesanici e diazacicloeptanici
|
|
HU214846B
(hu)
|
1993-08-24 |
1998-06-29 |
Janssen Pharmaceutica N.V. |
Eljárás baktériumok és rothadást okozó organizmusok irtására oxatiazinok és azok oxidjaival, valamint a vegyületeket tartalmazó bevonókompozíció
|
|
MX9406411A
(es)
|
1993-08-24 |
1997-08-30 |
Uniroyal Chem Co Inc |
Oxatiazinas conservadoras de madera.
|
|
EP0764639A4
(en)
|
1994-06-09 |
1997-10-01 |
Ss Pharmaceutical Co |
4-CHINOLINONE DERIVATIVE OR ITS SALT
|
|
IT1270594B
(it)
|
1994-07-07 |
1997-05-07 |
Recordati Chem Pharm |
Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida
|
|
US5759542A
(en)
|
1994-08-05 |
1998-06-02 |
New England Deaconess Hospital Corporation |
Compositions and methods for the delivery of drugs by platelets for the treatment of cardiovascular and other diseases
|
|
US5660854A
(en)
|
1994-11-28 |
1997-08-26 |
Haynes; Duncan H |
Drug releasing surgical implant or dressing material
|
|
US6316652B1
(en)
|
1995-06-06 |
2001-11-13 |
Kosta Steliou |
Drug mitochondrial targeting agents
|
|
US5798119A
(en)
|
1995-06-13 |
1998-08-25 |
S. C. Johnson & Son, Inc. |
Osmotic-delivery devices having vapor-permeable coatings
|
|
WO1997001331A2
(en)
|
1995-06-27 |
1997-01-16 |
Takeda Chemical Industries, Ltd. |
Method of producing sustained-release preparation
|
|
TW448055B
(en)
|
1995-09-04 |
2001-08-01 |
Takeda Chemical Industries Ltd |
Method of production of sustained-release preparation
|
|
JP2909418B2
(ja)
|
1995-09-18 |
1999-06-23 |
株式会社資生堂 |
薬物の遅延放出型マイクロスフイア
|
|
US6039975A
(en)
|
1995-10-17 |
2000-03-21 |
Hoffman-La Roche Inc. |
Colon targeted delivery system
|
|
US5663357A
(en)
|
1995-11-22 |
1997-09-02 |
Allergan |
Substituted heteroarylamides having retinoid-like biological activity
|
|
US5980945A
(en)
|
1996-01-16 |
1999-11-09 |
Societe De Conseils De Recherches Et D'applications Scientifique S.A. |
Sustained release drug formulations
|
|
TW345603B
(en)
|
1996-05-29 |
1998-11-21 |
Gmundner Fertigteile Gmbh |
A noise control device for tracks
|
|
US6264970B1
(en)
|
1996-06-26 |
2001-07-24 |
Takeda Chemical Industries, Ltd. |
Sustained-release preparation
|
|
US6419961B1
(en)
|
1996-08-29 |
2002-07-16 |
Takeda Chemical Industries, Ltd. |
Sustained release microcapsules of a bioactive substance and a biodegradable polymer
|
|
AU722289B2
(en)
|
1996-10-01 |
2000-07-27 |
Aptalis Pharmatech, Inc. |
Taste-masked microcapsule compositions and methods of manufacture
|
|
CA2217134A1
(en)
|
1996-10-09 |
1998-04-09 |
Sumitomo Pharmaceuticals Co., Ltd. |
Sustained release formulation
|
|
EP0839525B1
(en)
|
1996-10-31 |
2004-08-04 |
Takeda Chemical Industries, Ltd. |
Sustained-release preparation
|
|
US6131570A
(en)
|
1998-06-30 |
2000-10-17 |
Aradigm Corporation |
Temperature controlling device for aerosol drug delivery
|
|
DE69719367T2
(de)
|
1996-12-20 |
2003-10-16 |
Takeda Chemical Industries, Ltd. |
Verfahren zur herstellung einer zusammensetzung mit verzoegerter abgabe
|
|
CA2276034A1
(en)
|
1996-12-23 |
1998-07-02 |
Mimi Lifen Quan |
Oxygen or sulfur containing 5-membered heteroaromatics as factor xa inhibitors
|
|
US5891474A
(en)
|
1997-01-29 |
1999-04-06 |
Poli Industria Chimica, S.P.A. |
Time-specific controlled release dosage formulations and method of preparing same
|
|
US6120751A
(en)
|
1997-03-21 |
2000-09-19 |
Imarx Pharmaceutical Corp. |
Charged lipids and uses for the same
|
|
US6060082A
(en)
|
1997-04-18 |
2000-05-09 |
Massachusetts Institute Of Technology |
Polymerized liposomes targeted to M cells and useful for oral or mucosal drug delivery
|
|
JPH11209366A
(ja)
|
1998-01-23 |
1999-08-03 |
Nissan Chem Ind Ltd |
クロマン誘導体及び心不全治療薬
|
|
US6350458B1
(en)
|
1998-02-10 |
2002-02-26 |
Generex Pharmaceuticals Incorporated |
Mixed micellar drug deliver system and method of preparation
|
|
US6613358B2
(en)
|
1998-03-18 |
2003-09-02 |
Theodore W. Randolph |
Sustained-release composition including amorphous polymer
|
|
TR200003598T2
(tr)
|
1998-03-26 |
2001-06-21 |
Japan Tobacco Inc. |
Amid türevleri ve nosiseptin antagonistleri
|
|
PT957099E
(pt)
|
1998-04-15 |
2003-02-28 |
Pfizer Prod Inc |
Carboxamidas heterociclicas
|
|
US6048736A
(en)
|
1998-04-29 |
2000-04-11 |
Kosak; Kenneth M. |
Cyclodextrin polymers for carrying and releasing drugs
|
|
KR19990085365A
(ko)
|
1998-05-16 |
1999-12-06 |
허영섭 |
지속적으로 약물 조절방출이 가능한 생분해성 고분자 미립구 및그 제조방법
|
|
EP1028113A4
(en)
|
1998-08-04 |
2004-10-13 |
Toray Industries |
HETEROCYCLIC DERIVATIVES OF BENZENE IN FUSION AND THEIR USE
|
|
GB9823871D0
(en)
|
1998-10-30 |
1998-12-23 |
Pharmacia & Upjohn Spa |
2-Amino-thiazole derivatives, process for their preparation, and their use as antitumour agents
|
|
CN1325385A
(zh)
|
1998-11-09 |
2001-12-05 |
詹姆斯·布莱克基金有限公司 |
胃泌素和缩胆囊素受体配体
|
|
US6248363B1
(en)
|
1999-11-23 |
2001-06-19 |
Lipocine, Inc. |
Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
|
|
JP2000256358A
(ja)
|
1999-03-10 |
2000-09-19 |
Yamanouchi Pharmaceut Co Ltd |
ピラゾール誘導体
|
|
US6271359B1
(en)
|
1999-04-14 |
2001-08-07 |
Musc Foundation For Research Development |
Tissue-specific and pathogen-specific toxic agents and ribozymes
|
|
CZ20014679A3
(cs)
|
1999-06-24 |
2002-04-17 |
Nihon Nohyaku Co., Ltd. |
Diamidové deriváty heterocyklické dikarboxylové kyseliny, zemědělské a zahradnické insekticidy a způsob jejich pouľití
|
|
GEP20053476B
(en)
|
1999-08-12 |
2005-03-25 |
Upjohn Co |
3(5)-Amino-Pyrazole Derivatives, Process for Their Preparation and Their Use as Antitumor Agents
|
|
WO2001021160A2
(en)
|
1999-09-23 |
2001-03-29 |
Axxima Pharmaceuticals Aktiengesellschaft |
Carboxymide and aniline derivatives as selective inhibitors of pathogens
|
|
US6710205B2
(en)
|
2000-02-22 |
2004-03-23 |
Ono Pharmaceutical Co., Ltd. |
Benzoic acid derivatives, processes for producing the same and drugs containing the same as the active ingredient
|
|
GB0011098D0
(en)
|
2000-05-08 |
2000-06-28 |
Black James Foundation |
Pharmaceutical compositions comprising protpn pump inhibitors and gastrin/cholecystokinin receptor ligands
|
|
GB0018758D0
(en)
|
2000-07-31 |
2000-09-20 |
Smithkline Beecham Plc |
Novel use and compunds
|
|
MXPA03001771A
(es)
|
2000-08-30 |
2003-06-04 |
Pfizer Prod Inc |
Formulaciones de liberacion sostenida para secretagogos de hormona del crecimiento.
|
|
WO2002028353A2
(en)
|
2000-10-05 |
2002-04-11 |
Smithkline Beecham Corporation |
Phosphate transport inhibitors
|
|
US7151102B2
(en)
|
2000-10-30 |
2006-12-19 |
Kudos Pharmaceuticals Limited |
Phthalazinone derivatives
|
|
DE10061876A1
(de)
|
2000-12-12 |
2002-06-20 |
Aventis Pharma Gmbh |
Arylierte Furan- und Thiophencarbonsäureamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen
|
|
EP1688412A3
(en)
|
2001-02-16 |
2006-08-16 |
Aventis Pharmaceuticals, Inc. |
Novel heterocyclic amide derivatives and their use as dopamine D3 receptor ligands
|
|
GB0117531D0
(en)
|
2001-02-16 |
2001-09-12 |
Aventis Pharm Prod Inc |
Novel heterocyclic amide derivatives and their use as dopamine D3 receptor ligands
|
|
JP2002338537A
(ja)
|
2001-05-16 |
2002-11-27 |
Mitsubishi Pharma Corp |
アミド化合物およびその医薬用途
|
|
TW591020B
(en)
|
2001-06-20 |
2004-06-11 |
Wyeth Corp |
6-(aryl-amido or aryl-amidomethyl)-naphthalen-2-yloxy-acidic derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)
|
|
AU2002317377A1
(en)
|
2001-07-20 |
2003-03-03 |
Cancer Research Technology Limited |
Biphenyl apurinic/apyrimidinic site endonuclease inhibitors to treat cancer
|
|
US7544690B2
(en)
|
2001-10-01 |
2009-06-09 |
Taisho Pharmaceutical Co., Ltd. |
MCH receptor antagonists
|
|
GB0124939D0
(en)
|
2001-10-17 |
2001-12-05 |
Glaxo Group Ltd |
Chemical compounds
|
|
WO2003064389A1
(en)
|
2002-01-31 |
2003-08-07 |
Ono Pharmaceutical Co., Ltd. |
Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient
|
|
ATE489384T1
(de)
|
2002-05-06 |
2010-12-15 |
Vertex Pharma |
Thiadiazole oder oxadiazole und ihre verwendung als jak proteinkinaseinhibitoren
|
|
MXPA04012704A
(es)
|
2002-06-19 |
2005-03-23 |
Schering Corp |
Agonistas de los receptores canabinoides.
|
|
ATE425753T1
(de)
|
2002-08-02 |
2009-04-15 |
Genesoft Pharmaceuticals Inc |
Biaryl-verbindungen mit antiinfektiver wirkung
|
|
WO2004022551A1
(ja)
|
2002-09-06 |
2004-03-18 |
Takeda Pharmaceutical Company Limited |
フランまたはチオフェン誘導体およびその医薬用途
|
|
EP1562915A1
(en)
|
2002-11-22 |
2005-08-17 |
SmithKline Beecham Corporation |
Farnesoid x receptor agonists
|
|
US7223788B2
(en)
|
2003-02-14 |
2007-05-29 |
Sanofi-Aventis Deutschland Gmbh |
Substituted N-aryl heterocycles, process for their preparation and their use as medicaments
|
|
JP2004315511A
(ja)
|
2003-03-31 |
2004-11-11 |
Taisho Pharmaceut Co Ltd |
Ｍｃｈ受容体アンタゴニスト
|
|
US7262197B2
(en)
|
2003-03-31 |
2007-08-28 |
Janssen Pharmaceutica, N.V |
Phospholipase C inhibitors for use in treating inflammatory disorders
|
|
EP1626713A2
(en)
|
2003-05-16 |
2006-02-22 |
Ambit Biosciences Corporation |
Heterocyclic compounds and uses thereof
|
|
US20040248972A1
(en)
|
2003-05-16 |
2004-12-09 |
Ambit Biosciences Corporation |
Compounds and uses thereof
|
|
WO2004108133A2
(en)
|
2003-06-05 |
2004-12-16 |
Vertex Pharmaceuticals Incorporated |
Modulators of vr1 receptor
|
|
GB0315111D0
(en)
|
2003-06-27 |
2003-07-30 |
Cancer Rec Tech Ltd |
Substituted 5-membered ring compounds and their use
|
|
US20050222408A1
(en)
|
2003-07-14 |
2005-10-06 |
University Of Tennessee Research Foundation |
Heterocyclic amides with anti-tuberculosis activity
|
|
WO2005007625A2
(en)
|
2003-07-14 |
2005-01-27 |
The University Of Tennessee Research Foundation |
Heterocyclic amides with anti-tuberculosis activity
|
|
US7615563B2
(en)
|
2003-08-08 |
2009-11-10 |
Gonzalez Iii Jesus E |
Compositions useful as inhibitors of voltage-gated sodium channels
|
|
KR20060073930A
(ko)
|
2003-08-08 |
2006-06-29 |
버텍스 파마슈티칼스 인코포레이티드 |
통증 치료시 나트륨 또는 칼슘 채널 차단제로서 유용한헤테로아릴아미노설포닐페닐 유도체
|
|
NZ545134A
(en)
*
|
2003-09-18 |
2009-06-26 |
Lilly Co Eli |
Modulation of eIF4E expression
|
|
US7534894B2
(en)
|
2003-09-25 |
2009-05-19 |
Wyeth |
Biphenyloxy-acids
|
|
WO2005033072A2
(en)
|
2003-09-30 |
2005-04-14 |
Scios Inc. |
Heterocyclic amides and sulfonamides
|
|
GB0324269D0
(en)
|
2003-10-16 |
2003-11-19 |
Pharmagene Lab Ltd |
EP4 receptor antagonists
|
|
CA2545711A1
(en)
|
2003-11-13 |
2005-06-02 |
Ambit Biosciences Corporation |
Urea derivatives as kinase modulators
|
|
GB0329214D0
(en)
|
2003-12-17 |
2004-01-21 |
Glaxo Group Ltd |
Novel compounds
|
|
JP2005314347A
(ja)
|
2004-04-30 |
2005-11-10 |
Japan Tobacco Inc |
疼痛抑制剤
|
|
US7470722B2
(en)
*
|
2004-06-10 |
2008-12-30 |
Kalypsys, Inc. |
Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of disease
|
|
SE0401653D0
(sv)
|
2004-06-24 |
2004-06-24 |
Astrazeneca Ab |
New compounds
|
|
NZ552173A
(en)
|
2004-06-25 |
2010-07-30 |
Janssen Pharmaceutica Nv |
Quaternary salt CCR2 antagonists
|
|
DE102004039789A1
(de)
|
2004-08-16 |
2006-03-02 |
Sanofi-Aventis Deutschland Gmbh |
Arylsubstituierte polycyclische Amine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
|
KR20170001725A
(ko)
|
2004-09-02 |
2017-01-04 |
제넨테크, 인크. |
헤지호그 신호전달에 대한 피리딜 억제제
|
|
DE102004051277A1
(de)
|
2004-10-21 |
2006-04-27 |
Merck Patent Gmbh |
Heterocyclische Carbonylverbindungen
|
|
DE102004060227B3
(de)
|
2004-12-15 |
2006-07-20 |
Sanofi-Aventis Deutschland Gmbh |
Verfahren zur Herstellung von Oxazolen durch Kondensation von aromatischen Aldehyden mit α-Ketoximen zu N-Oxiden und nachfolgende Reaktion mit aktivierten Säurederivaten
|
|
EP1831168B1
(en)
|
2004-12-16 |
2014-07-02 |
Vertex Pharmaceuticals Inc. |
Pyrid-2-ones useful as inhibitors of tec family protein kinases for the treatment of inflammatory, proliferative and immunologically-mediated diseases.
|
|
US7592467B2
(en)
|
2005-04-11 |
2009-09-22 |
Probiodrug Ag |
Inhibitors of prolyl endopeptidase
|
|
WO2007016292A2
(en)
|
2005-07-27 |
2007-02-08 |
Vertex Pharmaceuticals Incorporated |
Heterocyclic amides as biofilm modulators
|
|
EP1922068A4
(en)
|
2005-08-16 |
2010-08-11 |
Icagen Inc |
INHIBITORS OF VOLTAGE-CONTROLLED SODIUM CHANNELS
|
|
CN101346357B
(zh)
|
2005-10-25 |
2014-04-02 |
盐野义制药株式会社 |
氨基二氢噻嗪衍生物
|
|
EP1963313B1
(en)
|
2005-11-28 |
2012-11-14 |
Madrigal Pharmaceuticals, Inc. |
Inhibitors of diacylglycerol acyltransferase (dgat)
|
|
BRPI0620464A2
(pt)
|
2005-12-23 |
2011-11-16 |
Astrazeneca Ab |
composto, composição farmacêutica, uso de um composto, e, método para o tratamento de uma doença
|
|
JP5385125B2
(ja)
|
2006-03-22 |
2014-01-08 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
ＭＤＭ２とｐ５３の間の相互作用の阻害剤
|
|
USRE45336E1
(en)
|
2006-05-18 |
2015-01-13 |
Arena Pharmaceuticals, Inc. |
Primary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
|
|
CA2668190A1
(en)
*
|
2006-11-03 |
2008-05-15 |
Irm Llc |
Compounds and compositions as protein kinase inhibitors
|
|
JP5577104B2
(ja)
*
|
2007-03-14 |
2014-08-20 |
エクセリクシス パテント カンパニー エルエルシー |
ヘッジホッグ経路の阻害剤
|
|
JP5383483B2
(ja)
|
2007-04-24 |
2014-01-08 |
塩野義製薬株式会社 |
アルツハイマー症治療用医薬組成物
|
|
EP2689780A1
(en)
|
2007-04-24 |
2014-01-29 |
Shionogi & Co., Ltd. |
Intermediates for aminodihydrothiazine derivatives substituted with a cyclic group
|
|
US20100137312A1
(en)
*
|
2007-05-15 |
2010-06-03 |
Neurosearch A/S |
Novel aromatic heterocyclic carboxylic acid amide derivatives useful as potassium channel modulators
|
|
US8153644B2
(en)
|
2007-05-22 |
2012-04-10 |
Madrigal Pharmaceuticals, Inc. |
Diacylglycerol acyltransferase inhibitors
|
|
US8115011B2
(en)
|
2007-05-22 |
2012-02-14 |
Madrigal Pharmaceuticals, Inc. |
Diacylglycerol acyltransferase inhibitors
|
|
US20090099201A1
(en)
|
2007-05-22 |
2009-04-16 |
David Robert Bolin |
Diacylglycerol Acyltransferase Inhibitors
|
|
US8058299B2
(en)
|
2007-05-22 |
2011-11-15 |
Via Pharmaceuticals, Inc. |
Diacylglycerol acyltransferase inhibitors
|
|
TW200920357A
(en)
|
2007-09-10 |
2009-05-16 |
Curis Inc |
HSP90 inhibitors containing a zinc binding moiety
|
|
US20090076275A1
(en)
|
2007-09-19 |
2009-03-19 |
David Robert Bolin |
Diacylglycerol acyltransferase inhibitors
|
|
EP2227453B1
(en)
|
2007-10-11 |
2016-03-09 |
Vertex Pharmaceuticals Incorporated |
Heteroaryl amides useful as inhibitors of voltage-gated sodium channels
|
|
US8168829B2
(en)
|
2007-10-26 |
2012-05-01 |
Janssen Pharmaceutica N.V. |
Synthesis of quaternary salt compounds
|
|
US8093428B2
(en)
|
2007-10-26 |
2012-01-10 |
Janssen Pharmaceutica N.V. |
Synthesis of quaternary salt compounds
|
|
EP2210876B1
(en)
|
2007-11-01 |
2015-05-20 |
Takeda Pharmaceutical Company Limited |
Heterocyclic compound as glucagon antagonist
|
|
RU2364597C1
(ru)
*
|
2007-12-14 |
2009-08-20 |
Андрей Александрович Иващенко |
ГЕТЕРОЦИКЛИЧЕСКИЕ ИНГИБИТОРЫ Hh-СИГНАЛЬНОГО КАСКАДА, ЛЕКАРСТВЕННЫЕ КОМПОЗИЦИИ НА ИХ ОСНОВЕ И СПОСОБ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ, СВЯЗАННЫХ С АББЕРАНТНОЙ АКТИВНОСТЬЮ Hh СИГНАЛЬНОЙ СИСТЕМЫ
|
|
US8642660B2
(en)
|
2007-12-21 |
2014-02-04 |
The University Of Rochester |
Method for altering the lifespan of eukaryotic organisms
|
|
DE102008007400A1
(de)
|
2008-02-04 |
2009-08-06 |
Bayer Healthcare Ag |
Substituierte Furane und ihre Verwendung
|
|
US8461348B2
(en)
|
2008-04-04 |
2013-06-11 |
Takeda Pharmaceutical Company Limited |
Heterocyclic derivative and use thereof
|
|
US20090281089A1
(en)
|
2008-04-11 |
2009-11-12 |
Genentech, Inc. |
Pyridyl inhibitors of hedgehog signalling
|
|
SG186229A1
(en)
*
|
2010-06-07 |
2013-01-30 |
Novomedix Llc |
Furanyl compounds and the use thereof
|